首页 > 最新文献

Health physics最新文献

英文 中文
Indoor Radon Concentrations in Severe Cold Area and Cold Area and Impact of Energy-saving Design on Indoor Radon in China. 中国严寒地区和寒冷地区室内氡浓度及节能设计对室内氡的影响。
IF 1 4区 医学 Q4 ENVIRONMENTAL SCIENCES Pub Date : 2024-12-01 Epub Date: 2024-07-24 DOI: 10.1097/HP.0000000000001869
Yunyun Wu, Yanchao Song, Changsong Hou, Hongxing Cui, Bing Shang, Haoran Sun

Abstract: This study investigated indoor radon concentrations in modern residential buildings in the Cold Area and Severe Cold Area in China. A total of 19 cities covering 16 provinces were selected with 1,610 dwellings measured for indoor radon concentration. The arithmetic mean and geometric mean of indoor radon concentration were 68 Bq m -3 and 57 Bq m -3 , respectively. It was found that indoor radon concentrations were much higher in the Severe Cold Area than those in the Cold Area. The indoor radon concentrations showed an increasing trend for newly constructed buildings. It was estimated that the average effective dose from inhalation of indoor radon is 2.15 mSv and 1.60 mSv for the Severe Cold Area and Cold Area, respectively. The more and more rigid energy-saving design for residential buildings in the Severe Cold Area and Cold Area has an obvious impact on the increased trend of indoor radon due to extremely low air exchange rate in China.

摘要:本研究调查了中国寒冷地区和严寒地区现代住宅建筑的室内氡浓度。研究共选取了 16 个省的 19 个城市,1,610 个住宅进行了室内氡浓度测量。室内氡浓度的算术平均值和几何平均值分别为 68 Bq m-3 和 57 Bq m-3。研究发现,严寒地区的室内氡浓度远高于寒冷地区。新建建筑物的室内氡浓度呈上升趋势。据估计,严寒地区和寒冷地区吸入室内氡的平均有效剂量分别为 2.15 mSv 和 1.60 mSv。由于中国空气交换率极低,严寒地区和寒冷地区住宅建筑的节能设计越来越严格,这对室内氡的增加趋势有明显的影响。
{"title":"Indoor Radon Concentrations in Severe Cold Area and Cold Area and Impact of Energy-saving Design on Indoor Radon in China.","authors":"Yunyun Wu, Yanchao Song, Changsong Hou, Hongxing Cui, Bing Shang, Haoran Sun","doi":"10.1097/HP.0000000000001869","DOIUrl":"10.1097/HP.0000000000001869","url":null,"abstract":"<p><strong>Abstract: </strong>This study investigated indoor radon concentrations in modern residential buildings in the Cold Area and Severe Cold Area in China. A total of 19 cities covering 16 provinces were selected with 1,610 dwellings measured for indoor radon concentration. The arithmetic mean and geometric mean of indoor radon concentration were 68 Bq m -3 and 57 Bq m -3 , respectively. It was found that indoor radon concentrations were much higher in the Severe Cold Area than those in the Cold Area. The indoor radon concentrations showed an increasing trend for newly constructed buildings. It was estimated that the average effective dose from inhalation of indoor radon is 2.15 mSv and 1.60 mSv for the Severe Cold Area and Cold Area, respectively. The more and more rigid energy-saving design for residential buildings in the Severe Cold Area and Cold Area has an obvious impact on the increased trend of indoor radon due to extremely low air exchange rate in China.</p>","PeriodicalId":12976,"journal":{"name":"Health physics","volume":" ","pages":"682-687"},"PeriodicalIF":1.0,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141758352","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Optimizing Regulatory Reviews for Clinical Protocols That Use Radiopharmaceuticals: Findings of the University of Pennsylvania Radiation Research Safety Committee. 优化使用放射性药物的临床方案的监管审查:宾夕法尼亚大学辐射研究安全委员会的研究成果。
IF 1 4区 医学 Q4 ENVIRONMENTAL SCIENCES Pub Date : 2024-12-01 Epub Date: 2024-08-01 DOI: 10.1097/HP.0000000000001873
Sylvia S Rhodes, Janelle E Jesikiewicz, Nikhil Yegya-Raman, Kavya Prasad, Alexandra Dreyfuss, David A Mankoff, Neil K Taunk

Abstract: Institutional radiation safety committees review research studies with radiation exposure. However, ensuring that the potential patient benefit and knowledge gained merit the radiation risks involved often necessitates revisions that inadvertently delay protocol activations. This quality-improvement study analyzed protocols, identified factors associated with approval time by a radiation safety committee, and developed guidelines to expedite reviews without compromising quality. Clinical protocols submitted to the University of Pennsylvania's Radiation Research Safety Committee (RRSC) for review between 2017 and 2021 were studied. Protocol characteristics, review outcome, stipulations, and approval times were summarized. Statistical analysis (Spearman's rho) was used to investigate stipulations and approval time; rank-sum analysis (Kruskal-Wallis or Wilcoxon) was used to determine whether approval time differed by protocol characteristics. One hundred ten (110) protocols were analyzed. Approximately two-thirds of protocols used approved radiopharmaceuticals to aid investigational therapy trials. Twenty-three percent (23%) of protocols received RRSC approval, and 73% had approval withheld with stipulations, which included requests for edits or additional information. Submissions had a median of three stipulations. Median and mean RRSC approval times were 62 and 80.1 d, and 41% of protocols received RRSC approval after IRB approval. RRSC approval time was positively correlated with stipulations (Spearman's rho = 0. 632, p < 0.001). RRSC approval time was longer for studies using investigational new drugs (median 80 d) than approved radiopharmaceuticals (median 57 d, p = 0.05). The review process is lengthy and may benefit from changes, including publishing standardized radiation safety language and commonly required documents and encouraging timely response to stipulations.

摘要:机构辐射安全委员会负责审查有辐射照射的研究项目。然而,为了确保潜在的患者获益和获得的知识能够抵消辐射风险,往往需要对方案进行修订,从而无意中延误了方案的启动。这项质量改进研究分析了研究方案,确定了与辐射安全委员会审批时间相关的因素,并制定了在不影响质量的前提下加快审查速度的指导原则。研究人员对 2017 年至 2021 年期间提交给宾夕法尼亚大学辐射研究安全委员会(RRSC)审查的临床方案进行了研究。总结了方案特征、审查结果、规定和批准时间。统计分析(Spearman's rho)用于调查规定和批准时间;秩和分析(Kruskal-Wallis 或 Wilcoxon)用于确定批准时间是否因方案特征而异。共分析了 110 份方案。约有三分之二的方案使用已获批准的放射性药物来辅助研究性治疗试验。23%的方案获得了RRSC的批准,73%的方案在获得批准的同时附有规定,其中包括要求编辑或提供更多信息。提交方案的规定中位数为三项。RRSC 批准时间的中位数和平均值分别为 62 天和 80.1 天,41% 的方案在获得 IRB 批准后才获得 RRSC 批准。RRSC 批准时间与规定呈正相关(Spearman's rho = 0. 632,p < 0.001)。与已批准的放射性药物(中位数为 57 d,p = 0.05)相比,使用研究性新药的研究的 RRSC 批准时间更长(中位数为 80 d)。审查过程冗长,可能会因改革而受益,包括发布标准化的辐射安全语言和通常要求的文件,以及鼓励对规定做出及时回应。
{"title":"Optimizing Regulatory Reviews for Clinical Protocols That Use Radiopharmaceuticals: Findings of the University of Pennsylvania Radiation Research Safety Committee.","authors":"Sylvia S Rhodes, Janelle E Jesikiewicz, Nikhil Yegya-Raman, Kavya Prasad, Alexandra Dreyfuss, David A Mankoff, Neil K Taunk","doi":"10.1097/HP.0000000000001873","DOIUrl":"10.1097/HP.0000000000001873","url":null,"abstract":"<p><strong>Abstract: </strong>Institutional radiation safety committees review research studies with radiation exposure. However, ensuring that the potential patient benefit and knowledge gained merit the radiation risks involved often necessitates revisions that inadvertently delay protocol activations. This quality-improvement study analyzed protocols, identified factors associated with approval time by a radiation safety committee, and developed guidelines to expedite reviews without compromising quality. Clinical protocols submitted to the University of Pennsylvania's Radiation Research Safety Committee (RRSC) for review between 2017 and 2021 were studied. Protocol characteristics, review outcome, stipulations, and approval times were summarized. Statistical analysis (Spearman's rho) was used to investigate stipulations and approval time; rank-sum analysis (Kruskal-Wallis or Wilcoxon) was used to determine whether approval time differed by protocol characteristics. One hundred ten (110) protocols were analyzed. Approximately two-thirds of protocols used approved radiopharmaceuticals to aid investigational therapy trials. Twenty-three percent (23%) of protocols received RRSC approval, and 73% had approval withheld with stipulations, which included requests for edits or additional information. Submissions had a median of three stipulations. Median and mean RRSC approval times were 62 and 80.1 d, and 41% of protocols received RRSC approval after IRB approval. RRSC approval time was positively correlated with stipulations (Spearman's rho = 0. 632, p < 0.001). RRSC approval time was longer for studies using investigational new drugs (median 80 d) than approved radiopharmaceuticals (median 57 d, p = 0.05). The review process is lengthy and may benefit from changes, including publishing standardized radiation safety language and commonly required documents and encouraging timely response to stipulations.</p>","PeriodicalId":12976,"journal":{"name":"Health physics","volume":" ","pages":"702-711"},"PeriodicalIF":1.0,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141893314","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Uranium in Drinking Water and Bladder Cancer: A Case-control Study in Michigan. 饮用水中的铀与膀胱癌:密歇根州病例对照研究》。
IF 1 4区 医学 Q4 ENVIRONMENTAL SCIENCES Pub Date : 2024-12-01 Epub Date: 2024-08-05 DOI: 10.1097/HP.0000000000001880
Perpetua Uduba, Lissa Soares, Tesleem Babalola, Melissa Slotnick, Aaron Linder, Jaymie R Meliker

Abstract: Uranium is naturally occurring in groundwater used for drinking; however, health risks from naturally occurring concentrations are uncertain. Uranium can cause both radiological and chemical toxicity following ingestion. Bladder and kidneys receive a dose when uranium is excreted into the urine. Investigate the association between uranium in drinking water and bladder cancer risk in a case-control study. A population-based bladder cancer case-control study was conducted in 11 counties of southeastern Michigan. A total of 411 cases and 566 controls provided drinking water and toenail samples and answered questions about lifestyle and residential history. Uranium was measured in drinking water and toenails, and its association with bladder cancer was assessed via unconditional logistic regression models. Median uranium concentration in water was 0.12 μg L -1 , with a maximum of 4.99 μg L -1 , and median uranium concentration in toenails was 0.0031 μg g -1 . In adjusted regression models, there was a suggestion of a protective effect among those exposed to the upper quartile of uranium in drinking water (HR = 0.64, 95% CI: 0.43, 0.96) and toenails (HR 0.66; 95% CI 0.45, 0.96) compared to those in the lowest quartile. Our objective is to investigate additional adjustment of drinking water source at home residence at time of recruitment to address potential selection bias and confounding attenuated results toward the null for drinking water uranium (HR = 0.68, 95% CI: 0.44, 1.05) and toenail uranium (HR = 0.80, 95% CI: 0.53, 1.20). This case-control study showed no increased risk of bladder cancer associated with uranium found in drinking water or toenails.

摘要:铀天然存在于饮用水的地下水中,但天然浓度对健康的危害尚不确定。铀摄入人体后会产生放射性和化学毒性。当铀随尿液排出体外时,膀胱和肾脏也会受到一定剂量的影响。在病例对照研究中调查饮用水中的铀与膀胱癌风险之间的关联。在密歇根州东南部的 11 个县开展了一项基于人群的膀胱癌病例对照研究。共有 411 名病例和 566 名对照者提供了饮用水和脚趾甲样本,并回答了有关生活方式和居住史的问题。对饮用水和脚趾甲中的铀进行了测量,并通过无条件逻辑回归模型评估了铀与膀胱癌的关系。水中铀浓度的中位数为 0.12 μg L-1,最大值为 4.99 μg L-1,脚趾甲中铀浓度的中位数为 0.0031 μg g-1。在调整后的回归模型中,与最低四分位数的人群相比,饮用水中铀含量处于最高四分位数的人群(HR = 0.64,95% CI:0.43,0.96)和脚趾甲中铀含量处于最低四分位数的人群(HR 0.66;95% CI 0.45,0.96)具有保护作用。我们的目标是对招募时家庭居住地的饮用水源进行额外调整,以解决潜在的选择偏差和混淆问题,使饮用水铀(HR = 0.68,95% CI:0.44,1.05)和脚趾甲铀(HR = 0.80,95% CI:0.53,1.20)的结果趋于无效。这项病例对照研究表明,膀胱癌风险的增加与饮用水或脚趾甲中发现的铀无关。
{"title":"Uranium in Drinking Water and Bladder Cancer: A Case-control Study in Michigan.","authors":"Perpetua Uduba, Lissa Soares, Tesleem Babalola, Melissa Slotnick, Aaron Linder, Jaymie R Meliker","doi":"10.1097/HP.0000000000001880","DOIUrl":"10.1097/HP.0000000000001880","url":null,"abstract":"<p><strong>Abstract: </strong>Uranium is naturally occurring in groundwater used for drinking; however, health risks from naturally occurring concentrations are uncertain. Uranium can cause both radiological and chemical toxicity following ingestion. Bladder and kidneys receive a dose when uranium is excreted into the urine. Investigate the association between uranium in drinking water and bladder cancer risk in a case-control study. A population-based bladder cancer case-control study was conducted in 11 counties of southeastern Michigan. A total of 411 cases and 566 controls provided drinking water and toenail samples and answered questions about lifestyle and residential history. Uranium was measured in drinking water and toenails, and its association with bladder cancer was assessed via unconditional logistic regression models. Median uranium concentration in water was 0.12 μg L -1 , with a maximum of 4.99 μg L -1 , and median uranium concentration in toenails was 0.0031 μg g -1 . In adjusted regression models, there was a suggestion of a protective effect among those exposed to the upper quartile of uranium in drinking water (HR = 0.64, 95% CI: 0.43, 0.96) and toenails (HR 0.66; 95% CI 0.45, 0.96) compared to those in the lowest quartile. Our objective is to investigate additional adjustment of drinking water source at home residence at time of recruitment to address potential selection bias and confounding attenuated results toward the null for drinking water uranium (HR = 0.68, 95% CI: 0.44, 1.05) and toenail uranium (HR = 0.80, 95% CI: 0.53, 1.20). This case-control study showed no increased risk of bladder cancer associated with uranium found in drinking water or toenails.</p>","PeriodicalId":12976,"journal":{"name":"Health physics","volume":" ","pages":"719-724"},"PeriodicalIF":1.0,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141893315","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Methods to Track Effective Doses from Airborne Radioactive Emissions for Compliance with 40 CFR 61, SUBPART H. 跟踪空气中放射性排放有效剂量的方法,以符合 40 CFR 61,H 分节的规定。
IF 1 4区 医学 Q4 ENVIRONMENTAL SCIENCES Pub Date : 2024-12-01 Epub Date: 2024-07-24 DOI: 10.1097/HP.0000000000001872
Amber M Harshman, William L McCarter

Abstract: US Department of Energy national laboratories can play an integral role in not only the advancement of science but also in the treatment of various medical conditions through research and development activities conducted at radioisotope production facilities. A project has been underway at Oak Ridge National Laboratory since 2016 whose mission is to produce and supply the radioisotope 227 Ac, which is used in a radiopharmaceutical developed to treat certain types of prostate cancer and bone metastases. Production activities result in the environmental release of airborne radioactive emissions, which are governed by Clean Air Act regulations described in 40 CFR Part 61, Subpart H. Stack 3039, the source that emits radioactive effluents from 227 Ac production, is subject to additional requirements outlined in American National Standards Institute (ANSI) N13.1-1969 due to its grandfathered status. Radioactive emissions are limited to levels below those that would cause annual compliance dose standards for members of the public to be exceeded and stack 3039 to lose its grandfathered status. To allow for maximum production of 227 Ac without exceeding relevant dose limits, monthly tracking of project emissions and resulting CAP88-PC modeled effective doses to a maximally exposed individual have been implemented. Four years of tracking data were compiled and analyzed to identify additional methods that could be used to estimate project doses more frequently, potentially further optimizing 227 Ac production while maintaining compliance with applicable regulations.

摘要:美国能源部国家实验室通过在放射性同位素生产设施开展研发活动,不仅能在科学进步方面发挥不可或缺的作用,还能在治疗各种病症方面发挥不可或缺的作用。自 2016 年以来,橡树岭国家实验室一直在开展一个项目,其任务是生产和供应放射性同位素 227Ac,该同位素用于开发一种放射性药物,以治疗某些类型的前列腺癌和骨转移。生产活动会导致空气中的放射性排放物释放到环境中,这些排放物受《清洁空气法》(Clean Air Act)第 40 CFR 61 部分 H 子部分的规定管辖。堆栈 3039 是 227Ac 生产过程中排放放射性废水的源头,由于其原始状态,因此必须遵守美国国家标准学会 (ANSI) N13.1-1969 中列出的额外要求。放射性排放被限制在低于会导致公众年度合规剂量标准超标和 3039 烟囱失去祖父地位的水平。为了在不超过相关剂量限制的情况下最大限度地生产 227Ac,对项目排放量和由此产生的 CAP88-PC 建模有效剂量进行了每月跟踪。对四年的跟踪数据进行了汇编和分析,以确定可用于更频繁地估算项目剂量的其他方法,从而有可能进一步优化 227Ac 的生产,同时保持符合适用法规。
{"title":"Methods to Track Effective Doses from Airborne Radioactive Emissions for Compliance with 40 CFR 61, SUBPART H.","authors":"Amber M Harshman, William L McCarter","doi":"10.1097/HP.0000000000001872","DOIUrl":"10.1097/HP.0000000000001872","url":null,"abstract":"<p><strong>Abstract: </strong>US Department of Energy national laboratories can play an integral role in not only the advancement of science but also in the treatment of various medical conditions through research and development activities conducted at radioisotope production facilities. A project has been underway at Oak Ridge National Laboratory since 2016 whose mission is to produce and supply the radioisotope 227 Ac, which is used in a radiopharmaceutical developed to treat certain types of prostate cancer and bone metastases. Production activities result in the environmental release of airborne radioactive emissions, which are governed by Clean Air Act regulations described in 40 CFR Part 61, Subpart H. Stack 3039, the source that emits radioactive effluents from 227 Ac production, is subject to additional requirements outlined in American National Standards Institute (ANSI) N13.1-1969 due to its grandfathered status. Radioactive emissions are limited to levels below those that would cause annual compliance dose standards for members of the public to be exceeded and stack 3039 to lose its grandfathered status. To allow for maximum production of 227 Ac without exceeding relevant dose limits, monthly tracking of project emissions and resulting CAP88-PC modeled effective doses to a maximally exposed individual have been implemented. Four years of tracking data were compiled and analyzed to identify additional methods that could be used to estimate project doses more frequently, potentially further optimizing 227 Ac production while maintaining compliance with applicable regulations.</p>","PeriodicalId":12976,"journal":{"name":"Health physics","volume":" ","pages":"688-701"},"PeriodicalIF":1.0,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141758353","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effect of Protective Eyewear on Physicians' Lens Exposure during Fluoroscopy. 防护眼镜对医生在荧光透视检查过程中镜片暴露的影响。
IF 1 4区 医学 Q4 ENVIRONMENTAL SCIENCES Pub Date : 2024-12-01 Epub Date: 2024-08-05 DOI: 10.1097/HP.0000000000001875
Takahira Hitomi, Kudo Takashi, Ideguchi Reiko

Abstract: The ICRP 2011 Seoul Statement recommended a reduction in the dose limit for lens exposure to 100 mSv for 5 y and 50 mSv for 1 y. Based on this recommendation, the dose limit for lens exposure was lowered in Japan with the revision of the Ionization Regulations, which took effect in April 2021. In the present study, lens doses were measured during fluoroscopic procedures performed in four departments (Urology, Pediatrics, Gastroenterology, and Orthopedics). Lens doses were measured without protective eyewear for 6 mo (pre-intervention) and then with protective eyewear for the next 6 mo (post-intervention). Monthly doses were collected and lens doses before and after the use of protective eyewear were calculated as the lens dose per unit time. The use of protective eyewear reduced the lens dose per unit time by approximately two thirds. In all departments, the lens dose was slightly lower after than before the intervention. A significant difference was observed in lens doses between the pre- and post-intervention periods in the Urology department. The present results demonstrated the effectiveness of protective eyewear in daily practice. Therefore, the use of protective eyewear is recommended during fluoroscopic procedures.

摘要:国际放射防护委员会 2011 年首尔声明建议将透镜照射的剂量限制降至 5 年 100 mSv 和 1 年 50 mSv。在本研究中,对四个科室(泌尿科、儿科、消化科和骨科)进行透视手术时的镜片剂量进行了测量。在未佩戴防护眼镜的情况下测量了 6 个月(干预前)的镜片剂量,然后在佩戴防护眼镜的情况下测量了 6 个月(干预后)的镜片剂量。每月收集镜片剂量,并将使用防护眼镜前后的镜片剂量计算为单位时间内的镜片剂量。使用防护眼镜后,单位时间内的镜片剂量减少了约三分之二。在所有部门,干预后的镜片剂量都略低于干预前。在泌尿科,干预前后的镜片剂量差异明显。本研究结果证明了防护眼镜在日常工作中的有效性。因此,建议在透视过程中使用防护眼镜。
{"title":"Effect of Protective Eyewear on Physicians' Lens Exposure during Fluoroscopy.","authors":"Takahira Hitomi, Kudo Takashi, Ideguchi Reiko","doi":"10.1097/HP.0000000000001875","DOIUrl":"10.1097/HP.0000000000001875","url":null,"abstract":"<p><strong>Abstract: </strong>The ICRP 2011 Seoul Statement recommended a reduction in the dose limit for lens exposure to 100 mSv for 5 y and 50 mSv for 1 y. Based on this recommendation, the dose limit for lens exposure was lowered in Japan with the revision of the Ionization Regulations, which took effect in April 2021. In the present study, lens doses were measured during fluoroscopic procedures performed in four departments (Urology, Pediatrics, Gastroenterology, and Orthopedics). Lens doses were measured without protective eyewear for 6 mo (pre-intervention) and then with protective eyewear for the next 6 mo (post-intervention). Monthly doses were collected and lens doses before and after the use of protective eyewear were calculated as the lens dose per unit time. The use of protective eyewear reduced the lens dose per unit time by approximately two thirds. In all departments, the lens dose was slightly lower after than before the intervention. A significant difference was observed in lens doses between the pre- and post-intervention periods in the Urology department. The present results demonstrated the effectiveness of protective eyewear in daily practice. Therefore, the use of protective eyewear is recommended during fluoroscopic procedures.</p>","PeriodicalId":12976,"journal":{"name":"Health physics","volume":" ","pages":"712-718"},"PeriodicalIF":1.0,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141893313","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Electret Production and Applications with Special Regard to Health Physics Dosimetry: A Review. 驻极体的生产和应用,特别是在健康物理剂量测定方面:综述。
IF 1 4区 医学 Q4 ENVIRONMENTAL SCIENCES Pub Date : 2024-11-27 DOI: 10.1097/HP.0000000000001896
Mehdi Sohrabi, Sahel Rabiee

Abstract: An electret detector is a piece of dielectric material film charged or polarized by a specific charging method to induce a quasi-permanent electric field. Electret films perform unique characteristics for production and applications in many areas of science and technology, especially in health physics dosimetry. A charged electret detector, when placed in an ionized environment, collects negative or positive ions depending on its original charging state, which reduces its original charge. The number of charges reduced in the ionized field is usually proportional to the absorbed radiation dose. In this paper, the state-of-the-art information on the type of electrets, production methods, some applications in particular in health physics dosimetry, and relevant concepts are reviewed.

摘要:驻极体探测器是一种介电材料薄膜,通过特定的充电方法对其充电或极化,从而诱发准永久性电场。驻极体薄膜具有独特的生产特性,可应用于许多科学技术领域,特别是健康物理剂量测定领域。带电的驻极体探测器置于电离环境中时,会根据其原始充电状态收集负离子或正离子,从而减少其原始电荷。电离场中减少的电荷数通常与吸收的辐射剂量成正比。本文回顾了有关电子体类型、生产方法、特别是在健康物理学剂量测定中的一些应用以及相关概念的最新信息。
{"title":"Electret Production and Applications with Special Regard to Health Physics Dosimetry: A Review.","authors":"Mehdi Sohrabi, Sahel Rabiee","doi":"10.1097/HP.0000000000001896","DOIUrl":"https://doi.org/10.1097/HP.0000000000001896","url":null,"abstract":"<p><strong>Abstract: </strong>An electret detector is a piece of dielectric material film charged or polarized by a specific charging method to induce a quasi-permanent electric field. Electret films perform unique characteristics for production and applications in many areas of science and technology, especially in health physics dosimetry. A charged electret detector, when placed in an ionized environment, collects negative or positive ions depending on its original charging state, which reduces its original charge. The number of charges reduced in the ionized field is usually proportional to the absorbed radiation dose. In this paper, the state-of-the-art information on the type of electrets, production methods, some applications in particular in health physics dosimetry, and relevant concepts are reviewed.</p>","PeriodicalId":12976,"journal":{"name":"Health physics","volume":" ","pages":""},"PeriodicalIF":1.0,"publicationDate":"2024-11-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142727888","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pre-declaration Fetal Dose Assignment and Predictive Full term Fetal Dose at Medical Facilities. 医疗机构申报前胎儿剂量分配和预测足月胎儿剂量。
IF 1 4区 医学 Q4 ENVIRONMENTAL SCIENCES Pub Date : 2024-11-20 DOI: 10.1097/HP.0000000000001914
James Kyle Underwood, Glenn M Sturchio

Abstract: Many medical facilities across the United States use ionizing-radiation-producing machines and radioactive materials for diagnostic and therapeutic purposes on a regular basis. While institutions are required to ensure full-term fetal doses are below the regulatory limit, clear guidance on how pre-declaration fetal doses should be estimated is not available. This paper provides a process that can be used to estimate the pre-declaration fetal dose and provides a predictive screening tool for licensees to use to recommend workload adjustments prior to actual fetal dosimetry results that could exceed the institutions derived investigation levels. The evaluation process presented herein serves as a guide for medical licensees when performing fetal dose evaluations for declared pregnant workers.

摘要:美国许多医疗机构经常使用产生电离辐射的机器和放射性物质进行诊断和治疗。虽然医疗机构必须确保足月胎儿剂量低于监管限值,但对于如何估算申报前胎儿剂量却没有明确的指导。本文提供了一个可用于估算申报前胎儿剂量的流程,并为持证者提供了一个预测性筛查工具,以便在实际胎儿剂量测定结果可能超过机构得出的调查水平之前,建议对工作量进行调整。本文介绍的评估流程可作为医疗许可证持有者对申报怀孕工人进行胎儿剂量评估时的指南。
{"title":"Pre-declaration Fetal Dose Assignment and Predictive Full term Fetal Dose at Medical Facilities.","authors":"James Kyle Underwood, Glenn M Sturchio","doi":"10.1097/HP.0000000000001914","DOIUrl":"https://doi.org/10.1097/HP.0000000000001914","url":null,"abstract":"<p><strong>Abstract: </strong>Many medical facilities across the United States use ionizing-radiation-producing machines and radioactive materials for diagnostic and therapeutic purposes on a regular basis. While institutions are required to ensure full-term fetal doses are below the regulatory limit, clear guidance on how pre-declaration fetal doses should be estimated is not available. This paper provides a process that can be used to estimate the pre-declaration fetal dose and provides a predictive screening tool for licensees to use to recommend workload adjustments prior to actual fetal dosimetry results that could exceed the institutions derived investigation levels. The evaluation process presented herein serves as a guide for medical licensees when performing fetal dose evaluations for declared pregnant workers.</p>","PeriodicalId":12976,"journal":{"name":"Health physics","volume":" ","pages":""},"PeriodicalIF":1.0,"publicationDate":"2024-11-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142675651","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical Best Practices for Radiation Safety During an Alpha DaRT Treatment. 阿尔法 DaRT 治疗期间辐射安全的临床最佳实践。
IF 1 4区 医学 Q4 ENVIRONMENTAL SCIENCES Pub Date : 2024-11-20 DOI: 10.1097/HP.0000000000001928
Yadin Cohen, Jon Feldman, Vibha Chaswal, Sarah Heard, Evelyn Shin, Giacomo Feliciani, Jean-Yves Giraud, Eleonora Kuptzov

Abstract: Alpha DaRT is a new alpha radiation treatment for treating solid tumors and is currently being evaluated through clinical trials worldwide. Being a novel radiation treatment, it is important to discuss the safety considerations and procedures that are needed to ensure safe use of this unique approach. The objective of this article is to provide a set of recommendations-radiation safety best practices that were developed based on operational and clinical experience.

摘要:α DaRT 是一种治疗实体瘤的新型α放射治疗方法,目前正在全球进行临床试验评估。作为一种新型放射治疗方法,讨论确保安全使用这种独特方法所需的安全注意事项和程序非常重要。本文旨在提供一套建议--根据操作和临床经验制定的放射安全最佳实践。
{"title":"Clinical Best Practices for Radiation Safety During an Alpha DaRT Treatment.","authors":"Yadin Cohen, Jon Feldman, Vibha Chaswal, Sarah Heard, Evelyn Shin, Giacomo Feliciani, Jean-Yves Giraud, Eleonora Kuptzov","doi":"10.1097/HP.0000000000001928","DOIUrl":"https://doi.org/10.1097/HP.0000000000001928","url":null,"abstract":"<p><strong>Abstract: </strong>Alpha DaRT is a new alpha radiation treatment for treating solid tumors and is currently being evaluated through clinical trials worldwide. Being a novel radiation treatment, it is important to discuss the safety considerations and procedures that are needed to ensure safe use of this unique approach. The objective of this article is to provide a set of recommendations-radiation safety best practices that were developed based on operational and clinical experience.</p>","PeriodicalId":12976,"journal":{"name":"Health physics","volume":" ","pages":""},"PeriodicalIF":1.0,"publicationDate":"2024-11-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142675649","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evaluation of a Commercially Available Radiochromic Film for Use as a Complementary Dosimeter for Rapid In-field Low Photon Equivalent Radiation Dose (≤50 mSv) Monitoring. 评估市售放射性变色膜作为辅助剂量计用于现场低光子当量辐射剂量(≤50 mSv)快速监测的情况。
IF 1 4区 医学 Q4 ENVIRONMENTAL SCIENCES Pub Date : 2024-11-20 DOI: 10.1097/HP.0000000000001903
Nicky Nivi, Helen Moise, Ana Pejović-Milić

Abstract: This work investigates the low photon radiation dose (≤50 mSv) response of commercially available radiochromic films as a potential field dosimeter that could be used by the Canadian Armed Forces to complement their existing personal radiation dosimeters. The films were exposed to various photon energies from x-ray devices and radioisotopes (cesium-137, cobalt-60, and americium-241), and their radiation signal was read using three methods: net optical density, UV/visible spectroscopy, and Fourier transform infrared spectroscopy. A complimentary film dosimeter for field usage should, for military use, display a visual color change and detect doses ≤50 mSv. Given the film's radiochromic properties, it was determined that the net optical density method was the most optimal read-out method, which ascertained a minimum detection dose limit of 4.5 mSv under exposure to a clinical orthovoltage operated at 100 kVp. The film presented an overall linear relationship between net optical density and radiation dose; however, they also portrayed a photon energy-dependent response between 0-100 mSv. Overall, the radiochromic films presented a real-time visual dose signal that could be interpreted rapidly in a mobile laboratory and possessed the ability to detect photon doses ≤50 mSv below the vendor's recommended limits, making it a suitable option as a complementary, disposable, military dosimetric tool. Future work includes the investigation of the film's response under multi- and unknown source environments and environmental-dependent factors such as UV/sunlight exposure and extreme temperatures.

摘要:这项工作研究了市售的放射性变色胶片对低光子辐射剂量(≤50 mSv)的响应,作为一种潜在的野外剂量计,加拿大武装部队可将其用于补充现有的个人辐射剂量计。这些胶片暴露在来自 X 射线设备和放射性同位素(铯-137、钴-60 和镅-241)的各种光子能量下,并使用三种方法读取其辐射信号:净光密度、紫外线/可见光光谱和傅立叶变换红外光谱。对于军事用途而言,野外使用的免费胶片剂量计应能显示视觉颜色变化,并能检测到≤50 mSv 的剂量。考虑到胶片的放射性变色特性,确定净光密度法是最理想的读出方法,在 100 kVp 的临床正交电压下,最低检测剂量限制为 4.5 mSv。胶片的净光密度与辐射剂量之间总体上呈线性关系,但在 0-100 mSv 之间也呈现出光子能量依赖性响应。总之,放射性变色薄膜能提供实时视觉剂量信号,可在移动实验室中快速解读,并能检测到低于供应商建议限值的 50 mSv 以下的光子剂量,因此适合作为一次性军用剂量测定工具的补充选择。未来的工作包括研究薄膜在多种和未知来源环境下的反应,以及紫外线/阳光照射和极端温度等环境相关因素。
{"title":"Evaluation of a Commercially Available Radiochromic Film for Use as a Complementary Dosimeter for Rapid In-field Low Photon Equivalent Radiation Dose (≤50 mSv) Monitoring.","authors":"Nicky Nivi, Helen Moise, Ana Pejović-Milić","doi":"10.1097/HP.0000000000001903","DOIUrl":"https://doi.org/10.1097/HP.0000000000001903","url":null,"abstract":"<p><strong>Abstract: </strong>This work investigates the low photon radiation dose (≤50 mSv) response of commercially available radiochromic films as a potential field dosimeter that could be used by the Canadian Armed Forces to complement their existing personal radiation dosimeters. The films were exposed to various photon energies from x-ray devices and radioisotopes (cesium-137, cobalt-60, and americium-241), and their radiation signal was read using three methods: net optical density, UV/visible spectroscopy, and Fourier transform infrared spectroscopy. A complimentary film dosimeter for field usage should, for military use, display a visual color change and detect doses ≤50 mSv. Given the film's radiochromic properties, it was determined that the net optical density method was the most optimal read-out method, which ascertained a minimum detection dose limit of 4.5 mSv under exposure to a clinical orthovoltage operated at 100 kVp. The film presented an overall linear relationship between net optical density and radiation dose; however, they also portrayed a photon energy-dependent response between 0-100 mSv. Overall, the radiochromic films presented a real-time visual dose signal that could be interpreted rapidly in a mobile laboratory and possessed the ability to detect photon doses ≤50 mSv below the vendor's recommended limits, making it a suitable option as a complementary, disposable, military dosimetric tool. Future work includes the investigation of the film's response under multi- and unknown source environments and environmental-dependent factors such as UV/sunlight exposure and extreme temperatures.</p>","PeriodicalId":12976,"journal":{"name":"Health physics","volume":" ","pages":""},"PeriodicalIF":1.0,"publicationDate":"2024-11-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142675650","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ionizing Radiation Dose to the Skin Assessed after Rapid Detection of 232Th in Consumer Products. 快速检测消费品中的 232Th 后评估的皮肤电离辐射剂量。
IF 1 4区 医学 Q4 ENVIRONMENTAL SCIENCES Pub Date : 2024-11-08 DOI: 10.1097/HP.0000000000001891
Christine Karbiwnyk, Philip Stafford, Elon Malkin, Kelly Garnick, Thomas A Scott, Cong Wei

Abstract: After some consumer products indicated elevated levels of 232Th progeny by gamma-ray spectrometry, a microwave digestion and inductively coupled plasma-mass spectrometry (ICP-MS) procedure was implemented for the direct assay of 232Th content to ensure compliance with Federal regulations and guidelines. Levels of 232Th were determined by ICP-MS based on standard calibration using a 205Tl internal standard. The method had a method detection limit (MDL) of 0.15 Bq g-1 and a lower limit of quantification (LLOQ) of 0.65 Bq g-1 for 232Th, making it a suitable confirmatory method following gamma-ray spectrometry. The 232Th activity concentration calculated from the ICP-MS results ranged from 2.0-3.4 Bq g-1 for the kinesiology tape samples and 20 Bq g-1 for the silicone ion bracelet. The VARSKIN+1.0 software program was used to calculate the shallow dose equivalent of ionizing radiation from 232Th and its progeny from the ICP-MS results. The skin dose to the consumer wearing the kinesiology tape ranged from 0.48-1.6 mSv y-1. The skin dose to the consumer with constant wear of the silicone ion bracelet was estimated to be 17 mSv y-1. Although 232Th may be determined indirectly by assay of high abundance gamma rays produced by its progeny, the US Code of Federal Regulations (CFR) requires the direct assay of 232Th for confirmatory analysis. We found this ICP-MS method to be a rapid 232Th confirmatory technique compared to a chemical separation followed by alpha spectrometry procedure.

摘要:一些消费品的伽马射线光谱分析结果显示 232Th 原物含量升高,因此采用了微波消解和电感耦合等离子体质谱法(ICP-MS)程序直接测定 232Th 含量,以确保符合联邦法规和准则。在使用 205Tl 内标进行标准校准的基础上,通过 ICP-MS 测定 232Th 含量。该方法的 232Th 检测限(MDL)为 0.15 Bq g-1,定量下限(LLOQ)为 0.65 Bq g-1,因此是伽马射线光谱法之后的一种合适的确认方法。根据 ICP-MS 结果计算出的 232Th 放射性浓度,运动带样品为 2.0-3.4 Bq g-1,硅离子手镯为 20 Bq g-1。我们使用 VARSKIN+1.0 软件程序,根据 ICP-MS 的结果计算 232Th 及其原生物质电离辐射的浅层剂量当量。佩戴运动胶带的消费者的皮肤剂量为 0.48-1.6 mSv y-1。据估计,持续佩戴硅离子手镯的消费者的皮肤剂量为 17 mSv y-1。虽然 232Th 可以通过检测其后代产生的高丰度伽马射线来间接测定,但美国联邦法规(CFR)要求直接检测 232Th 以进行确证分析。我们发现,与先进行化学分离再进行阿尔法光谱分析的程序相比,这种 ICP-MS 方法是一种快速的 232Th 确认技术。
{"title":"Ionizing Radiation Dose to the Skin Assessed after Rapid Detection of 232Th in Consumer Products.","authors":"Christine Karbiwnyk, Philip Stafford, Elon Malkin, Kelly Garnick, Thomas A Scott, Cong Wei","doi":"10.1097/HP.0000000000001891","DOIUrl":"https://doi.org/10.1097/HP.0000000000001891","url":null,"abstract":"<p><strong>Abstract: </strong>After some consumer products indicated elevated levels of 232Th progeny by gamma-ray spectrometry, a microwave digestion and inductively coupled plasma-mass spectrometry (ICP-MS) procedure was implemented for the direct assay of 232Th content to ensure compliance with Federal regulations and guidelines. Levels of 232Th were determined by ICP-MS based on standard calibration using a 205Tl internal standard. The method had a method detection limit (MDL) of 0.15 Bq g-1 and a lower limit of quantification (LLOQ) of 0.65 Bq g-1 for 232Th, making it a suitable confirmatory method following gamma-ray spectrometry. The 232Th activity concentration calculated from the ICP-MS results ranged from 2.0-3.4 Bq g-1 for the kinesiology tape samples and 20 Bq g-1 for the silicone ion bracelet. The VARSKIN+1.0 software program was used to calculate the shallow dose equivalent of ionizing radiation from 232Th and its progeny from the ICP-MS results. The skin dose to the consumer wearing the kinesiology tape ranged from 0.48-1.6 mSv y-1. The skin dose to the consumer with constant wear of the silicone ion bracelet was estimated to be 17 mSv y-1. Although 232Th may be determined indirectly by assay of high abundance gamma rays produced by its progeny, the US Code of Federal Regulations (CFR) requires the direct assay of 232Th for confirmatory analysis. We found this ICP-MS method to be a rapid 232Th confirmatory technique compared to a chemical separation followed by alpha spectrometry procedure.</p>","PeriodicalId":12976,"journal":{"name":"Health physics","volume":" ","pages":""},"PeriodicalIF":1.0,"publicationDate":"2024-11-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142604381","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Health physics
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1